Unlike previous studies, which have primarily concentrated on well-established pathways such as WNT and TGF-Beta, this research investigates the molecular alterations within the MAPK and JAK/STAT pathways, which play critical roles in tumor progression, immune response, and therapy resistance. Here, TGFB1 is linked to neoplasm.